Dr Craig Cormick is, amongst many things, a science communicator. He has a broad background in both the theory and the practice of working with social attitudes to new technologies, and methods of community engagement. Particularly, Craig is interested in how different values influence attitudes and receptiveness to messages or behaviour change. Continue reading → Synbio profile interview – Craig Cormick
Monica Espinosa Gomez is a PhD Candidate in the Paulsen SynBio Group at Macquarie University. Earlier this year she was awarded a CSIRO Synthetic Biology Future Science Platform PhD Scholarship. While undertaking her Bachelors of Biotechnology (Hons), Molecular Biotechnology, at UQ she worked in numerous labs as a research assistant. In 2016, she worked under synthetic biologist, Dr Claudia Vickers, at the Australian Institute for Bioengineering and Nanotechnology before embarking on her PhD journey in 2017. Twitter handle: @monicaespgom Continue reading → Synbio profile interview – Monica Espinosa
by Jestin George
Even though plans to colonise Mars are progressing rapidly, it is very hard to actually comprehend what a permanent life out there would be like. One can’t help but imagine it to be pretty Earth-centric; we will need to design spaces and resource solutions that provide what we need and use down here, out there. Food will definitely be an issue; Continue reading → Synthetic biology solutions for Mars colonization
Dr Michele Fabris is a CSIRO Synthetic Biology FPS Fellow, working on a diverse group of microalgae called diatoms. He is a core member of the Algal Biosystems and Biotechnology group led by Prof. Peter Ralph in Climate Change Cluster, of the University of Technology Sydney (C3:UTS), and a CSIRO Visiting Scientist in the group of A/Prof. Claudia Vickers. Michele completed his Ph.D. in 2013, where he worked on the reconstruction of diatom metabolic networks, and characterised novel aspects of diatom metabolism. Twitter handle: @fabrismichele
Dominic Logel is a PhD Candidate in Department of Molecular Sciences, Macquarie University, Sydney. He was recently awarded the CSIRO Future Science Platform PhD Top Up Scholarship. Dominic began his journey into synthetic biology research in 2013 as a member of Macquarie University iGEM team. Dominic hopes to use his research to further the design of organisms to provide useful benefits to humanity, be that in food production or medical applications. Twitter handle: @DominicLogel
Dr Alison McLennan is an Assistant Professor at Faculty of Business, Government and Law, University of Canberra. Alison is particularly interested in the challenges posed to regulation by emerging technologies, especially biotechnologies. Her PhD investigated regulation of synthetic biology and was awarded in 2014. In 2017, she presented the legal issues relating to synthetic biology at the SBA conference held in Sydney. She has continued to publish work on SynBio regulation and patent law, including for general audiences via The Conversation, and has a new book about synthetic biology law and policy issues coming out in 2018. Alison is interested in how we can not only manage the risks of new technologies, but also maximise their potential benefits. Twitter handle: @asmclennan
We are excited to present synthetic biologist, Dr Karen Weynberg, who is the ECR representative of SBA Executive Board. Karen is a CSIRO Future Science Research Fellow based at University of Queensland.
She completed her PhD in the UK in 2009, uncovering new viruses that infect marine phytoplankton. Her first fellowship, the ARC Super Science Research Fellowship, investigated the role of viruses in coral reefs. Her current fellowship uses synthetic biology to develop phage therapy for addressing bacterial biofilms and antibiotic resistance. Suffice to say that Karen is something of a virus aficionado, and has even given a TedX talk and media interviews to BBC News and ABC News. Twitter handle: @ReefViruses
If you are reading this post, you probably have an interest in synthetic biology, its potential, and the way it challenges our typical perceptions of biology as a field.
by Jestin George
In 2012 the first evidence of CRISPR-Cas9 genome editing was published and since then, almost 4000 CRISPR-Cas9 articles have followed. From fundamental research to applications in biotechnology, agriculture, health care, pest control, and synthetic biology, there is no doubt that CRISPR systems will revolutionise both biological research and indeed, technology, as we know it. Continue reading → CRISPR-Cas9 genome editing: from Cancer Treatment to Agriculture